Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,964 | 2,479 | 5,915 | 4,058 | 2,274 |
| Cost of Goods | N/A | N/A | 78 | 335 | 439 |
| Gross Profit | 1,964 | 3,331 | 5,836 | 3,722 | 1,835 |
| Operating Expenses | 26,270 | 19,630 | 27,843 | 37,977 | 47,815 |
| Operating Income | -24,306 | -17,151 | -21,929 | -33,920 | -45,541 |
| Interest Expense | 4,912 | 11,552 | 1,416 | 21,916 | 3,087 |
| Other Income | 1,072 | -882 | 2,555 | -5,951 | 23,149 |
| Pre-tax Income | -28,146 | -29,585 | -20,790 | -61,786 | -25,480 |
| Income Tax | -244 | -2,543 | -240 | 51 | 1,821 |
| Net Income Continuous | -27,902 | -27,042 | -20,550 | -61,838 | -27,301 |
| Net Income Discontinuous | N/A | -19,649 | 479 | -8,018 | -6,304 |
| Net Income | $-27,902 | $-46,691 | $-20,071 | $-69,856 | $-33,605 |
| EPS Basic Total Ops | -0.54 | -0.89 | -0.43 | -1.58 | -0.78 |
| EPS Basic Continuous Ops | -0.54 | -0.49 | -0.44 | -1.40 | -0.63 |
| EPS Basic Discontinuous Ops | N/A | -0.41 | 0.01 | -0.18 | -0.15 |
| EPS Diluted Total Ops | -0.54 | -0.89 | -0.43 | -1.58 | -0.78 |
| EPS Diluted Continuous Ops | -0.54 | -0.49 | -0.44 | -1.40 | -0.63 |
| EPS Diluted Discontinuous Ops | N/A | -0.41 | 0.01 | -0.18 | -0.15 |
| EBITDA(a) | $-24,306 | $-17,151 | $-21,929 | $-33,920 | $-45,541 |